Transient occult cardiotoxicity in children receiving continuous beta-agonist therapy.

about

Opioid Facilitation of β-Adrenergic Blockade: A New Pharmacological Condition?Comprehensive review of cardiovascular toxicity of drugs and related agents.

P2860

Q40478722-598D27C5-EB65-41D8-9DCD-431531FAD034 Q47556269-5E280238-B407-4856-B312-978F8D3FDCBF

P2860

Transient occult cardiotoxicity in children receiving continuous beta-agonist therapy.

Item

http://www.wikidata.org/entity/Q38193724

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Transient occult cardiotoxicity in children receiving continuous beta-agonist therapy.

@en

type

Item

label

Transient occult cardiotoxicity in children receiving continuous beta-agonist therapy.

@en

prefLabel

Transient occult cardiotoxicity in children receiving continuous beta-agonist therapy.

@en

P1476

Transient occult cardiotoxicity in children receiving continuous beta-agonist therapy.

@en

P2093

Allison Cowl

http://www.w3.org/2001/XMLSchema#string

Christopher L Carroll

http://www.w3.org/2001/XMLSchema#string

Craig M Schramm

http://www.w3.org/2001/XMLSchema#string

Kathleen A Sala

http://www.w3.org/2001/XMLSchema#string

Melinda Coro

http://www.w3.org/2001/XMLSchema#string

P2860

Acute asthma in the pediatric emergency department.

Status asthmaticus in children: a review.

Acid-base disturbances in acute asthma.

Metabolic acidosis as an underlying mechanism of respiratory distress in children with severe acute asthma.

Lactic acidosis and status asthmaticus: how common in pediatrics?

Elevated plasma lactate level associated with high dose inhaled albuterol therapy in acute severe asthma

Adverse effects of beta-agonists: are they clinically relevant?

Slow-responders to IV beta2-adrenergic agonist therapy: defining a novel phenotype in pediatric asthma.

Advances in treating acute asthma exacerbations in children.

High-dose MDI salbutamol treatment of asthma in the ED.

P2888

s12519-014-0467-z

P304

324-329

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12519-014-0467-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260558911

http://www.w3.org/2001/XMLSchema#string

P6179

1028540245

http://www.w3.org/2001/XMLSchema#string

P698

24599614

http://www.w3.org/2001/XMLSchema#string

Transient occult cardiotoxicity in children receiving continuous beta-agonist therapy.

about

P2860

P2860

Transient occult cardiotoxicity in children receiving continuous beta-agonist therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698